Bit.bio

Bit.bio is an award-winning human synthetic biology company that aims to become the world's leading supplier of in vitro cell types for academic research and commercial drug discovery and development. These cells can replace the limited supply of primary cells and, in other cases, replace animal research. Bit.bio’s patented technology rapidly generates highly mature, differentiated cell types with unparalleled purity. The process is scalable, expanding product availability and increasing cell types within the neuro-mesodermal focus areas. Initial products will include cortical neurons, oligodendrocytes, and skeletal muscle cells, marketed to academic research groups and pharmaceutical/biotech customers.